INS and hyperinsulinism: Enhancement of insulin sensitivity, aiding in the regulation of glucose levels and mitigating the risk of type 2 diabetes. Reduction of hyperinsulinemia, addressing insulin-driven androgen production and symptoms associated with androgen excess. Management of metabolic complications, such as hyperinsulinemia and dyslipidemia, contributing to overall metabolic health improvement.